关于贝叶斯逻辑回归方法在瘤学剂量检测研究中的相对保守性
Cheng-Han Yang1, Guanghui Cheng2, Ruitao Lin3
1Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Pharmaceutical statistics
|February 6, 2024
概括
对于瘤学剂量检测研究的标准贝叶斯逻辑回归方法 (BLRM) 通常过于保守. 本研究讨论了其保守性,并提出了一项剂量切换规则,以改善临床试验中的性能.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
背景情况:
- 贝叶斯逻辑回归方法 (BLRM) 是早期瘤学试验中剂量发现的标准方法.
- BLRM的设计受到过度保守的批评,可能会阻碍有效的剂量升级.
- 这种保守性通常归因于标准BLRM中使用的过量控制规则.
研究的目的:
- 分析标准贝叶斯逻辑回归方法 (BLRM) 的相对保守性.
- 提出一种新的剂量切换规则,以提高BLRM在瘤学剂量检测研究中的性能.
- 解决贝叶斯剂量发现设计中过度保守的问题.
主要方法:
- 对BLRM标准设计与拟议修改的比较分析.
- 讨论最近在医学统计学论文中引入的整体控制规则.
- 引入和评估一个新的剂量切换规则,以提高BLRM的性能.
主要成果:
- 标准BLRM设计表现出显著的保守性,影响剂量升级效率.
- 拟议的剂量切换规则提供了一个潜在的策略,以减轻BLRM的保守性.
- 讨论的整体控制规则旨在提高标准BLRM的性能.
结论:
- 标准BLRM设计的保守性需要对瘤学第一阶段研究的方法改进.
- 一个剂量切换规则可以提高贝叶斯剂量检测方法的性能和效率.
- 对细化贝叶斯设计的进一步研究对于优化癌症药物开发至关重要.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Parametric Survival Analysis: Weibull and Exponential Methods
436
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
436
Assumptions of Survival Analysis
128
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
128
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
The Mantel-Cox Log-Rank Test
368
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
368


